BEGIN:VCALENDAR PRODID:-//eluceo/ical//2.0/EN VERSION:2.0 CALSCALE:GREGORIAN BEGIN:VEVENT UID:cdf52b8ba8cb098c12e4121c7faff30b DTSTAMP:20260313T023548Z SUMMARY:Alumni Insights: Sensing\, Empowering and Shaping Health Equitably DESCRIPTION:How might new approaches and technologies help us to sense heal th needs earlier\, empower individuals and communities to take control of their health\, and shape health systems and technologies that are smarter and more inclusive?\nJoin Imperial alumni for an evening panel event explo ring how convergence science can contribute to more equitable health outco mes worldwide.\nThe panel discussion will be chaired by Professor Anthony Bull FREng\, Convening Director of the Health and Technology theme within Imperial’s School of Convergence Science. \nOur interdisciplinary alumn i panel will reflect on emerging tools\, approaches and ways of working th at have the potential to support prevention\, improve access\, and respond to health challenges across diverse populations and settings.\nIn additio n to the panel conversation\, attendees will get to experience a round of quick-fire pitches by Imperial founders\, highlighting how the university ’s innovation ecosystem is moving from concept to society\, to empower p atients as well as professionals and shape more inclusive health systems a nd technologies.\nThe evening will conclude with a networking reception\, offering you the chance to connect with fellow alumni\, speakers\, founder s and members of the Imperial community over refreshments.\nKey details \n Date: Tuesday 24 February\nTime: 18.30 – 20.45\nLocation: 12th Floor\, S ir Michael Uren Hub\, White City Campus\nCost: £10 for alumni and guests\ , £5 for students\nRegister: book your spot now via Eventbrite.\nEvent hi ghlights:\n\nExpert alumni panel discussion chaired by Professor Anthony B ull\nImperial startup showcase \nNetworking reception with snacks and drin ks\n\nPanellists \nLucy (Soo Min) Jung (MSc Innovation Design Engineering 2019)\n\nFounder of LYEONS and Charco Neurotech\, and an inventor of neur omodulation medical devices dedicated to improving the quality of life for people with long-term conditions. She is passionate about developing pati ent-centred solutions that combine technology\, empathy\, and accessibilit y.\n At LYEONS\, she leads the development of next-generation neuromodulat ion technology focused on autonomic nervous system regulation to support p eople experiencing anxiety\, stress\, trauma\, and sleep disturbances. The company’s patient-first approach builds on her previous experiences at Charco Neurotech\, where she led the creation of a device that significant ly improved mobility symptoms in people with Parkinson’s. They have succ essfully raised over £14 million through venture capital\, angel investor s\, and grant funding. Recently\, Lucy was winner of the Entrepreneur Alum ni Award 2025.\n\nMichael Barker (MBA 2001)\n\nMichael currently holds the post of National Strategy Director for the NHS’s New Hospital Programme . He has a lifelong career in healthcare\, and is a Consultant Physiothera pist by background. He has held many healthcare executive posts at board l evel\, leading complex projects that have set a new future for\, and succe ssfully transformed\, healthcare organisations. \nDuring the COVID-19 pand emic\, he returned to clinical leadership as the Head of Physiotherapy for NHS Nightingale Hospital\, London. He then spent 18 months at the Departm ent of Health and Social Care leading the role out of the LAMP (saliva) CO VID-19 testing programme. Alongside his current role\, he has also created and led an initiative called ‘Healthcare London’\, a partnership of p rivate providers in London who are unlocking access for international pati ents to advance their care in London.\n\nClaire Trant (PhD Materials 2020) \n\nScientist and Founder of Untap Health\, working to make early illness detection more proactive\, practical\, and accessible. Untap Health\, buil ds near-source\, non-invasive monitoring systems that provide early warnin g of viral and bacterial infectious risk before symptoms appear. The work at Untap Health spans both human and animal health\, supporting care envir onments\, workplaces\, farms\, livestock settings\, and other shared envir onments to act earlier\, reduce disruption\, and protect people and animal welfare. \nClaire is passionate about translating rigorous science into r eal-world tools\, and about building health protection infrastructure that is calm\, privacy-preserving\, and trustworthy.\n\nDr Chiara Bucciarelli- Ducci (PhD Cardiovascular Imaging 2012)\n\nConsultant Cardiologist at Roya l Brompton & Harefield Hospitals. Alongside her current clinical and teach ing commitments\, Chiara is CEO of international non-profit Society for Ca rdiovascular Magnetic Resonance (SCMR)\, the principal international\, ind ependent organisation committed to the further development of CMR through education\, quality control\, research\, and training. \nChiara was winner of the Emerging Alumni Leader Award 2022. Discover her story here.\n\nImp erial founders showcasing at this event \nThe Evidence Company \n\nBuildi ng trustworthy\, explainable AI agents for healthcare that can call and sp eak with millions of patients simultaneously – preparing them for surger y\, checking in post-procedure\, and enabling proactive care by identifyin g those who need support early. \nThe company works with leading healthcar e providers and medical device manufacturers across the UK\, EU and US to reduce clinical and administrative burden through evidence-based\, near-ze ro-hallucination AI. Founded by alumnus Uddhav Vaghela (MBBS Medicine 2020 ).\n\nProtonDx\n\nAn innovative MedTech startup that spun out from Imperia l in December 2020\, established to commercialise the multidisciplinary r esearch led by founders Professor Pantelis Georgiou\, Dr Jesus Rodriguez M anzano\, and Dr Nicolas Moser. Its mission is to transform disease managem ent and improve health outcomes by using ground-breaking sample preparatio n and detection technologies to develop diagnostic tests for priority infe ctions to be used at the point of need. \nIt aims to enable better healthc are through fast\, portable\, accurate\, connected\, and multiplex diagnos tic technology that facilitate the decentralisation of testing\, improve i nfection management and reduce inappropriate antimicrobial use\, a key dri ver of antimicrobial resistance (AMR). ProtonDx’s tests are suitable for across sectors including food\, environmental\, livestock and animal/huma n healthcare. Its flagship Lacewing platform marks a new frontier in point -of-care molecular diagnostics using Lab-on-Chip Technology. \nThe team ha ve also commercialised Dragonfly PoC diagnostic device\, which been adapte d and field-deployed for detection of malaria and skin tropic viruses. \ nTheir first customers included athletes from Team GB at the Beijing 2022 Winter Olympics and the 2022 Commonwealth Games\, and has travelled fr om the Arctic to Zambia\, demonstrating the portability and versatility of the technology. ProtonDx was recently crowned winner of the 2025 Tesco A gri T-Jam innovation challenge.\n\nAlphaVectors Biotech\n\nAlphaVectors Bi otech is on a mission to transform RNA-based therapeutics by addressing so me of the field’s biggest hurdles: stability and delivery efficiency. Ou r scalable\, cold-chain-free nanoparticle technology enables a ten-fold re duction in dose requirements while remaining stable at room temperature\, unlocking more affordable\, accessible vaccines and gene therapies worldwi de. \nWith significant commercial traction\, including a validation study with a world-leading pharmaceutical company\, AlphaVectors Biotech is redu cing logistical barriers and accelerating the impact of next-generation RN A medicines. Co-founded by alumnus Apanpreet Kaur (Chemical Engineering\, 2022)\n\nAbout the Chair\nProfessor Anthony Bull is Convening Director of the Health and Technology theme within Imperial’s School of Convergen ce Science\, and Professor of Musculoskeletal Mechanics in the Department of Bioengineering.\n \nHis research is focused on the basic mechanics of joints (including the tissues of joints and the mechanics of joints within the whole musculoskeletal system) and the application of this knowledge a nd technologies developed to the diagnosis and treatment of pathologies an d performance parameters. These are applied to sport biomechanics\, injury biomechanics (focusing on blast)\, and the biomechanics of ageing includi ng osteoarthritis. \nHe leads the Centre for Blast Injury Studies that exi sts to improve the mitigation of injury\, improve and advance treatment\, rehabilitation and recovery thus increasing lifelong health and quality of life after blast injury. \nAbout Imperial’s School of Convergence Scien ce \nThis event reflects the mission of Imperial’s School of Convergenc e Science: Health and Technology\, which exists to drive meaningful collab oration between disciplines\, methods and mindsets to tackle society’s m ost complex health challenges. \nBy fostering collaboration across boundar ies\, the School seeks to shift the focus from treating illness to sustain ing lifelong health – with equity\, agency\, and convergence science at its core.\nRead more about the School here.\n  URL:https://www.imperial.ac.uk/events/203547/alumni-insights-sensing-empowe ring-and-shaping-health-equitably/ DTSTART;TZID=Europe/London:20260224T183000 DTEND;TZID=Europe/London:20260224T204500 LOCATION:12th floor\, Sir Michael Uren Hub\, White City Campus\, Imperial C ollege London\, London\, W12 0BZ\, United Kingdom END:VEVENT BEGIN:VTIMEZONE TZID:Europe/London BEGIN:STANDARD DTSTART:20260224T183000 TZNAME:GMT TZOFFSETTO:+0000 TZOFFSETFROM:+0000 END:STANDARD END:VTIMEZONE END:VCALENDAR